Abstract
Intramuscular injection of naked plasmid DNA is known (1–3) to elicit humoral and cell-mediated immune responses against the encoded antigen. It is thought (2,3) that immunity follows DNA uptake by muscle cells, leading to the expression and extracellular release of the antigen which is then taken up by antigen presenting cells (APC). In addition, it is feasible that some of the injected DNA is taken up directly by APC. Disadvantages (1–3) of naked DNA vaccination include: uptake of DNA by only a minor fraction of muscle cells, exposure of DNA to deoxyribonuclease in the interstitial fluid thus necessitating the use of relatively large quantities of DNA, and, in some cases, injection into regenerating muscle in order to enhance immunity. We have recently proposed (1,4) that DNA immunization via liposomes (phospholipid vesicles) could circumvent the need of muscle involvement and instead facilitate (5) uptake of DNA by APC infiltrating the site of injection or in the lymphatics, at the same time protecting DNA from nuclease attack (6). Moreover, transfection of APC with liposomal DNA could be promoted by the judicial choice of vesicle surface charge, size and lipid composition, or by the co-entrapment, together with DNA, of plasmids expressing appropriate cytokines (e.g., interleukin 2), or immunostimulatory sequences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gregoriadis, G. (1998) Genetic vaccines: strategies for optimization. Pharm. Res. 15, 661–670.
Davis, H. L., Whalen, R. G., and Demeneix, B. A. (1993) Direct gene transfer in skeletal muscle in vivo: factors influencing efficiency of transfer and stability of expression, Hum. Gene Ther. 4, 151–156.
Manickan, E., Karem, K. L., and Rouse, B. T. (1997) DNA vaccines—a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17, 139–154.
Gregoriadis, G., Saffie, R., and de Souza, J. B. (1997) Liposome-mediated DNA vaccination. FEBS Lett. 402, 107–110.
Gregoriadis, G. (1995) Engineering targeted liposomes: Progress and problems. Trends Biotechnol. 13, 527–537.
Gregoriadis, G., Saffie, R., and Hart, S. L. (1996) High yield incorporation of plasmid DNA within liposomes: Effect on DNA integrity and transfection efficiency. J. Drug Targeting 3, 469–475.
Perrie, Y. and Gregoriadis, G. (1998) Liposome-mediated vaccination: the effect of vesicle composition. J. Liposome Res. 8, 95,96.
Obrenovic, M., Perrie, Y., and Gregoriadis, G. (1998) Entrapment of plasmid DNA into niosomes: characterization studies. J. Pharm. Pharmacol. 50, 155.
Gregoriadis, G., Davis, D., and Davies, A. (1987) Liposomes as immunological adjuvants: Antigen incorporation studies. Vaccine 5, 143–149.
Gregoriadis, G., ed. (1993) Liposome Technology, 2nd ed., Vols I–III, CRC Press, Boca Raton, FL.
Kirby, C. and Gregoriadis, G. (1984) Dehydration-rehydration vesicles (DRV): A new method for high yield drug entrapment in liposomes. Biotechnology 2, 979–984.
Skalko, N., Bouwstra, J., Spies, F., and Gregoriadis, G. (1996) The effect of microfluidization of protein-coated liposomes on protein distribution on the surface of generated small vesicles. Biochim. Biophys. Acta 1301, 249–254.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Gregoriadis, G., McCormack, B., Obrenovich, M., Perrie, Y. (2000). Entrapment of Plasmid DNA Vaccines into Liposomes by Dehydration/Rehydration. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:305
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:305
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols